Radiotherapy Trends and Variations in Invasive Non-metastatic Breast Cancer Treatment in the Netherlands: A Nationwide Overview From 2008 to 2019.

Autor: Evers J; Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research and Development, PO Box 19079, 3501 DB Utrecht, The Netherlands; University of Twente, Department of Health Technology and Services Research, Technical Medical Center, Hallenweg 5, 7522 NH Enschede, The Netherlands. Electronic address: J.Evers@iknl.nl., van der Sangen MJC; Catharina Hospital, Department of Radiation Oncology Michelangelolaan 2, 5623 EJ Eindhoven, The Netherlands., van Maaren MC; University of Twente, Department of Health Technology and Services Research, Technical Medical Center, Hallenweg 5, 7522 NH Enschede, The Netherlands; Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research and Development, PO Box 19079, 3501 DB Utrecht, The Netherlands., Maduro JH; University of Groningen, University Medical Center Groningen, Department of Radiation Oncology, Hanzeplein 1, 9713 GZ, Groningen, the Netherlands., Strobbe L; Canisius Wilhelmina Hospital, Department of Surgery Weg door Jonkerbos 100, 6532 SZ Nijmegen, The Netherlands., Aarts MJ; Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research and Development, PO Box 19079, 3501 DB Utrecht, The Netherlands., Bloemers MCWM; The Netherlands Cancer Institute, Department of Radiation Oncology Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., van den Bongard DHJG; Amsterdam University Medical Centers, Department of Radiation Oncology, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., Struikmans H; Leiden University Medical Center, Department of Radiation Oncology Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Siesling S; Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research and Development, PO Box 19079, 3501 DB Utrecht, The Netherlands; University of Twente, Department of Health Technology and Services Research, Technical Medical Center, Hallenweg 5, 7522 NH Enschede, The Netherlands.

Publikováno v: Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2024 Aug 22. Date of Electronic Publication: 2024 Aug 22.

Hyperbaric Oxygen Therapy and Late Local Toxic Effects in Patients With Irradiated Breast Cancer: A Randomized Clinical Trial.

Autor: Mink van der Molen DR; Division of Imaging and Oncology, University Medical Centre Utrecht, Cancer Centre, Utrecht, the Netherlands., Batenburg MCT; Division of Imaging and Oncology, University Medical Centre Utrecht, Cancer Centre, Utrecht, the Netherlands., Maarse W; Department of Plastic, Reconstructive and Hand Surgery, University Medical Centre Utrecht, Utrecht, the Netherlands., van den Bongard DHJG; Department of Radiation Oncology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Doeksen A; Department of Surgery, St Antonius Hospital, Nieuwegein, the Netherlands., de Lange MY; Alexander Monro Hospital, Bilthoven, the Netherlands., van der Pol CC; Department of Surgery, Alrijne Hospital, Leiderdorp, the Netherlands., Evers DJ; Department of Surgery, Hospital Group Twente, Hengelo, the Netherlands., Lansdorp CA; Da Vinci Clinic, Rotterdam, the Netherlands., van der Laan J; Division of Imaging and Oncology, University Medical Centre Utrecht, Cancer Centre, Utrecht, the Netherlands., van de Ven PM; The Julius Center for Health Sciences and Primary Care, Utrecht, the Netherlands., van der Leij F; Department of Radiation Oncology, University Medical Centre Utrecht, Cancer Centre, Utrecht, the Netherlands., Verkooijen HM; Division of Imaging and Oncology, University Medical Centre Utrecht, Cancer Centre, Utrecht, the Netherlands.

Publikováno v: JAMA oncology [JAMA Oncol] 2024 Apr 01; Vol. 10 (4), pp. 464-474.

Changes in breast cancer treatment during the COVID-19 pandemic: a Dutch population-based study.

Autor: Eijkelboom AH; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Department of Health Technology and Services Research, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands., de Munck L; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Menke-van der Houven van Oordt CW; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC Location VUMC, Amsterdam, The Netherlands., Broeders MJM; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.; Dutch Expert Centre for Screening, Nijmegen, The Netherlands., van den Bongard DHJG; Department of Radiation Oncology, Amsterdam UMC, Amsterdam, The Netherlands., Strobbe LJA; Department of Surgical Oncology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands., Mureau MAM; Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Lobbes MBI; Department of Medical Imaging, Zuyderland Medical Center Sittard-Geleen, Geleen, The Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.; School for Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, The Netherlands., Westenend PJ; Laboratory of Pathology, Dordrecht, The Netherlands., Koppert LB; Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Siemerink EJM; Department of Internal Medicine, Ziekenhuis Groep Twente, Hengelo, The Netherlands., Wesseling J; Division of Diagnostic Oncology and Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Verkooijen HM; Division of Imaging and Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands., Vrancken Peeters MTFD; Department of Surgery, Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.; Department of Surgery, Amsterdam UMC, Amsterdam, The Netherlands., Smidt ML; Department of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, School for Oncology and Developmental Biology (GROW), Maastricht University Medical Centre, Maastricht, The Netherlands., Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. s.siesling@utwente.nl.; Department of Health Technology and Services Research, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands. s.siesling@utwente.nl.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Jan; Vol. 197 (1), pp. 161-175. Date of Electronic Publication: 2022 Nov 05.

AI-Based Radiation Dose Quantification for Estimation of Heart Disease Risk in Breast Cancer Survivors After Radiation Therapy.

Autor: van Velzen SGM; Image Sciences Institute, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Biomedical Engineering and Physics, Amsterdam University Medical Centers - Location AMC, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: s.g.m.vanvelzen@amsterdamumc.nl., Gal R; Division of Imaging and Oncology, University Medical Center Utrecht, University of Utrecht, Utrecht, the Netherlands., Teske AJ; Department of Cardiology, University Medical Center Utrecht, University of Utrecht, Utrecht, the Netherlands., van der Leij F; Department of Radiation Oncology, University Medical Center Utrecht, University of Utrecht, Utrecht, the Netherlands., van den Bongard DHJG; Department of Radiation Oncology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Viergever MA; Image Sciences Institute, University Medical Center Utrecht, Utrecht, the Netherlands., Verkooijen HM; Division of Imaging and Oncology, University Medical Center Utrecht, University of Utrecht, Utrecht, the Netherlands., Išgum I; Image Sciences Institute, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Biomedical Engineering and Physics, Amsterdam University Medical Centers - Location AMC, University of Amsterdam, Amsterdam, the Netherlands; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers - Location AMC, University of Amsterdam, Amsterdam, the Netherlands; Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers - Location AMC, Amsterdam, the Netherlands.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2022 Mar 01; Vol. 112 (3), pp. 621-632. Date of Electronic Publication: 2021 Oct 06.

Health-related quality of life of early-stage breast cancer patients after different radiotherapy regimens.

Autor: Jacobs DHM; Department of Radiation Oncology, Leiden University Medical Center, Albinusdreef 2, PO box 9600, 2300 RC, Leiden, The Netherlands. d.h.m.jacobs@lumc.nl.; Department of Radiation Oncology, Haaglanden Medical Center, Burgemeester Banninglaan, 2262 BA, Leidschendam, The Netherlands. d.h.m.jacobs@lumc.nl., Charaghvandi RK; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Horeweg N; Department of Radiation Oncology, Leiden University Medical Center, Albinusdreef 2, PO box 9600, 2300 RC, Leiden, The Netherlands., Maduro JH; Department of Radiation Oncology, University Medical Center, Groningen, Groningen, The Netherlands., Speijer G; Department of Radiation Oncology, Haga Hospital, The Hague, The Netherlands., Roeloffzen EMA; Department of Radiation Oncology, Isala Clinics, Zwolle, The Netherlands., Mast M; Department of Radiation Oncology, Haaglanden Medical Center, Burgemeester Banninglaan, 2262 BA, Leidschendam, The Netherlands., Bantema-Joppe E; Department of Radiation Oncology, Radiotherapy Institute Friesland, Friesland, The Netherlands., Petoukhova AL; Department of Radiation Oncology, Haaglanden Medical Center, Burgemeester Banninglaan, 2262 BA, Leidschendam, The Netherlands., van den Bongard DHJG; Department of Radiation Oncology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Koper P; Department of Radiation Oncology, Haaglanden Medical Center, Burgemeester Banninglaan, 2262 BA, Leidschendam, The Netherlands., Crijns APG; Department of Radiation Oncology, University Medical Center, Groningen, Groningen, The Netherlands., Marijnen CAM; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Verkooijen HM; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Sep; Vol. 189 (2), pp. 387-398. Date of Electronic Publication: 2021 Jul 03.